Recruiting

CUPIDCarotid Flow Time & Peak Velocity Variability for Predicting Intradialytic Hypotension

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study is looking at how well Carotid Flow Time and Peak Velocity Variability can predict low blood pressure during dialysis. We will measure these values using ultrasound and analyze their ability to predict hypotension episodes.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Urogenital Diseases+15

+ Bronchiolitis Obliterans Syndrome

+ Organizing Pneumonia

From 18 to 80 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: February 2025
See protocol details

Summary

Principal SponsorFirst Affiliated Hospital of Wannan Medical College
Study ContactQiancheng Xu
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2025

Actual date on which the first participant was enrolled.

This study is designed to explore how certain measurements from an ultrasound can predict drops in blood pressure during dialysis, a common treatment for people with end-stage renal disease (ESRD). The study focuses on two specific measures: carotid corrected flow time (FTc) and peak flow velocity variability (PFVV). These measures are important because they could help foresee episodes of low blood pressure, which can be risky for patients on dialysis. By better predicting these episodes, healthcare providers can improve the safety and effectiveness of dialysis. The study includes adults with ESRD who have been on long-term dialysis for at least three months, excluding those with acute kidney injury or severe heart problems. Participants in the study undergo an ultrasound scan to measure FTc and PFVV one hour after their dialysis session begins. Additionally, their blood pressure is monitored throughout the procedure. Researchers then analyze the data to see how well FTc and PFVV can predict low blood pressure during dialysis. The aim is to find a simple and non-invasive way to monitor patients in real time, enhancing personalized care and safety during their treatment. This study uses advanced statistical methods to ensure accurate results, which could lead to better management strategies for patients undergoing hemodialysis.

Official TitleThe Predictive Value of Carotid Corrected Flow Time and Peak Flow Velocity Variability for Intradialytic Hypotension: A Prospective Multicenter Observational Study
Principal SponsorFirst Affiliated Hospital of Wannan Medical College
Study ContactQiancheng Xu
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

183 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 80 Years

Range of ages for which participants are eligible to join.

Conditions

Pathology

Urogenital DiseasesBronchiolitis Obliterans SyndromeOrganizing PneumoniaBronchial DiseasesBronchiolitisBronchiolitis ObliteransBronchitisFemale Urogenital Diseases and Pregnancy ComplicationsGraft vs Host DiseaseImmune System DiseasesKidney DiseasesLung DiseasesLung Diseases, ObstructiveRespiratory Tract DiseasesUremiaUrologic DiseasesFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

Inclusion Criteria: Adults aged 18 to 80 years. Diagnosed with end-stage renal disease (ESRD). Undergoing maintenance hemodialysis for more than three months. Willing and able to provide informed consent and comply with study procedures. Exclusion Criteria: Patients with significant carotid artery stenosis due to heavy atherosclerotic plaque (defined as more than 70% stenosis confirmed by ultrasound or angiography). Hemodynamically unstable patients or those requiring vasopressor support. Patients with significant arrhythmias (e.g., atrial fibrillation, ventricular tachycardia). Dialysis sessions terminated for reasons unrelated to hypotension (e.g., technical issues, patient request). Use of antihypertensive medications during dialysis sessions. Inability to undergo ultrasound assessment due to factors such as severe obesity or wounds obstructing access. Patients who withdraw informed consent during the study.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

Wuhu, ChinaOpen The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) in Google Maps
Recruiting
One Study Center